Literature DB >> 34661916

Liver-humanized mice: A translational strategy to study metabolic disorders.

Yonghong Luo1,2, Haocheng Lu1, Daoquan Peng2, Xiangbo Ruan3, Yuqing Eugene Chen1,4, Yanhong Guo1.   

Abstract

The liver is the metabolic core of the whole body. Tools commonly used to study the human liver metabolism include hepatocyte cell lines, primary human hepatocytes, and pluripotent stem cells-derived hepatocytes in vitro, and liver genetically humanized mouse model in vivo. However, none of these systems can mimic the human liver in physiological and pathological states satisfactorily. Liver-humanized mice, which are established by reconstituting mouse liver with human hepatocytes, have emerged as an attractive animal model to study drug metabolism and evaluate the therapeutic effect in "human liver" in vivo because the humanized livers greatly replicate enzymatic features of human hepatocytes. The application of liver-humanized mice in studying metabolic disorders is relatively less common due to the largely uncertain replication of metabolic profiles compared to humans. Here, we summarize the metabolic characteristics and current application of liver-humanized mouse models in metabolic disorders that have been reported in the literature, trying to evaluate the pros and cons of using liver-humanized mice as novel mouse models to study metabolic disorders.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  animal; liver; liver-humanized mice; metabolic disorders; metabolism; models

Mesh:

Year:  2021        PMID: 34661916      PMCID: PMC9126562          DOI: 10.1002/jcp.30610

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.513


  121 in total

Review 1.  The role of non-parenchymal cells in liver growth.

Authors:  Raza Malik; Clare Selden; Humphrey Hodgson
Journal:  Semin Cell Dev Biol       Date:  2002-12       Impact factor: 7.727

2.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

Review 3.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

4.  A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia.

Authors:  Max A Cayo; Sunil K Mallanna; Francesca Di Furio; Ran Jing; Lauren B Tolliver; Matthew Bures; Amanda Urick; Fallon K Noto; Evanthia E Pashos; Matthew D Greseth; Maciej Czarnecki; Paula Traktman; Wenli Yang; Edward E Morrisey; Markus Grompe; Daniel J Rader; Stephen A Duncan
Journal:  Cell Stem Cell       Date:  2017-04-06       Impact factor: 24.633

5.  Near completely humanized liver in mice shows human-type metabolic responses to drugs.

Authors:  Chise Tateno; Yasumi Yoshizane; Naomi Saito; Miho Kataoka; Rie Utoh; Chihiro Yamasaki; Asato Tachibana; Yoshinori Soeno; Kinji Asahina; Hiroshi Hino; Toshimasa Asahara; Tsuyoshi Yokoi; Toshinori Furukawa; Katsutoshi Yoshizato
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 6.  Ultrastructure of the liver and biliary tract in health and disease.

Authors:  P J Goldblatt; W T Gunning
Journal:  Ann Clin Lab Sci       Date:  1984 Mar-Apr       Impact factor: 1.256

7.  Liver-stage development of Plasmodium falciparum, in a humanized mouse model.

Authors:  Serban Morosan; Stéphanie Hez-Deroubaix; Francoise Lunel; Laurent Renia; Carlo Giannini; Nico Van Rooijen; Serena Battaglia; Catherine Blanc; Wijnand Eling; Robert Sauerwein; Laurent Hannoun; Jacques Belghiti; Christian Brechot; Dina Kremsdorf; Pierre Druilhe
Journal:  J Infect Dis       Date:  2006-02-28       Impact factor: 5.226

Review 8.  Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.

Authors:  Christopher Goldring; Daniel J Antoine; Frank Bonner; Jonathan Crozier; Chris Denning; Robert J Fontana; Neil A Hanley; David C Hay; Magnus Ingelman-Sundberg; Satu Juhila; Neil Kitteringham; Beatriz Silva-Lima; Alan Norris; Chris Pridgeon; James A Ross; Rowena Sison Young; Danilo Tagle; Belen Tornesi; Bob van de Water; Richard J Weaver; Fang Zhang; B Kevin Park
Journal:  Hepatology       Date:  2016-11-30       Impact factor: 17.425

9.  Comparison of circulating lipid profiles between fasting humans and three animal species used in preclinical studies: mice, rats and rabbits.

Authors:  Masaki Ishikawa; Kosuke Saito; Masayo Urata; Yuji Kumagai; Keiko Maekawa; Yoshiro Saito
Journal:  Lipids Health Dis       Date:  2015-09-10       Impact factor: 3.876

10.  Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.

Authors:  Chise Tateno; Yosuke Kawase; Yoshimi Tobita; Satoko Hamamura; Hiroki Ohshita; Hiroshi Yokomichi; Harumi Sanada; Masakazu Kakuni; Akira Shiota; Yuha Kojima; Yuji Ishida; Hiroshi Shitara; Naoko A Wada; Hiromi Tateishi; Masayuki Sudoh; Shin-Ichiro Nagatsuka; Kou-Ichi Jishage; Michinori Kohara
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more
  1 in total

Review 1.  Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives.

Authors:  Anna Zerdoug; Marc Le Vée; Shotaro Uehara; Béatrice Lopez; Christophe Chesné; Hiroshi Suemizu; Olivier Fardel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-07-06       Impact factor: 2.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.